Asbestos Litigation Trends: Understanding Disease, Jurisdiction, and Plaintiff Firm Strategies
lazupardo2024-04-22T05:46:04-04:00Asbestos litigation remains a dynamic and pivotal facet of the legal realm, holding profound consequences for both victims and implicated industries. In this enlightening session, we will unravel the intricate factors that shape legal proceedings involving asbestos. Our panel of experts will delve into crucial subjects, encompassing recent advancements in diagnosing and treating asbestos-related diseases, navigating the complexities of jurisdictional challenges within asbestos cases, and elucidating the strategic approaches employed by plaintiff firms to construct formidable cases. Furthermore, we will scrutinize contemporary trends within asbestos litigation, dissecting the legal intricacies and regulations that exert influence on this legal domain.
Unveiling the Impact: Notable Developments Shaping Restrictive Covenants
Ahmed Zidan2024-04-22T21:05:30-04:00Redefining Security Operations with Managed Defense
lazupardo2024-04-22T05:35:23-04:00In this LIVE Webcast, a panel of thought leaders and professionals brought together by The Knowledge Group will provide and present an in-depth analysis of the fundamentals as well as recent developments in Redefining Security Operations with Autonomous SOC. Speakers will also present all important issues surrounding this significant topic. Join us for this Knowledge Group Webinar!
What’s Shaping Tax Controversy in the US: Leading Issues Examined
lazupardo2023-10-11T22:11:19-04:00Tax controversy is as a major concern of businesses across industries primarily due to intensified scrutiny on tax avoidance practices. As the market rapidly evolves, tax disputes are becoming more prevalent both domestically and globally, posing significant challenges for multinational companies. These companies often find themselves entangled in tax disputes across different jurisdictions, placing a considerable strain on their resources.
Navigating Challenges in Patent Damages Analysis: Key Considerations for Litigants and Counsel
lazupardo2023-12-14T09:44:17-05:00Damages in patent infringement cases are nearly always hotly contested, in part because the underlying case law involving lost profits and reasonable royalties can be confusing and sometimes seemingly contradictory. Parties routinely engage in motion practice resulting in the exclusion of damages opinions, potentially derailing a case. Thus, it is imperative for both litigants and counsel to stay abreast of the latest trends and developments in patent damages to sidestep potential pitfalls.
Resilience and Reinvention: Navigating Corporate Bankruptcy and Reorganization
Joenel2023-09-19T21:36:38-04:00Corporate bankruptcy filings in the United States have surged in 2023, with over 230 companies seeking Chapter 11 protection, the highest number since 2010. This increase is due to economic difficulties, including a sluggish economy, increasing interest rates, and ongoing inflation.
Patent Damages: Strategies and Best Practices for Successful Litigation
lazupardo2023-09-27T03:48:10-04:00In today’s competitive business landscape, companies have become more aggressive in guarding their patented inventions. As new court rulings emerge and the U.S. Patent and Trademark Office (PTO) continues to enforce stringent rules and regulations on patent damages, calculating reasonable royalties and lost profits have become more complex. Proving and recovering damages in court requires a rigorous understanding of the intricacies involved in patent infringement actions and developing a strategic approach to boost the chances of success becomes paramount.
Federal White Collar Fraud Prosecutions: Examining the Supreme Court’s New Restrictions
Joenel2023-08-10T22:37:16-04:00Critical Issues in Hatch-Waxman Litigation
Marvin Monzon2023-12-18T22:17:23-05:00The pharmaceutical labeling carve-out regulations remain a source of complexity in several cases. The Hatch-Waxman Act created a way for the Food and Drug Administration (FDA) to approve generic drugs even if they omit information about protected use to encourage competition among generic products. However, following the Teva v. GSK ruling, businesses must exercise caution and recognize the intricate relationship between Orange Book listed use patents, reference listed drug’s prescribing information, and promotional labeling and other related activities.
Antitrust Class Certification: Staying Ahead of the Curve Amid Evolving Standards
Joenel2023-08-08T22:50:51-04:00Understanding R&D Tax Credits and Amortization: Navigating Changes and Maximizing Benefits
Joenel2024-03-15T09:40:24-04:00Responding to Ethical Dilemmas in the Accounting Profession
Ahmed Zidan2023-06-22T04:47:07-04:00Accountants are often faced with situations that challenge their ethical principles and standards. Failure to respond to these situations appropriately can lead to severe consequences, such as legal and reputational damage.